Effect of the Thiotepa Dose in the TBF Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission: A Report From the EBMT Acute Leukemia Working Party. [electronic resource]
Producer: 20210601Description: 296-304 p. digitalISSN:- 2152-2669
- Adult
- Aged
- Allografts
- Busulfan -- administration & dosage
- Disease-Free Survival
- Follow-Up Studies
- Hematopoietic Stem Cell Transplantation
- Humans
- Leukemia, Myeloid, Acute -- mortality
- Male
- Middle Aged
- Retrospective Studies
- Survival Rate
- Thiotepa -- administration & dosage
- Transplantation Conditioning
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.